Thermo Fisher Scientific Inc (TN8) Presyo ng Stock at Balita

(USD)	Mar 2025	Y/Y na pagbabago
Kita	10.36B	0.18%
Gastos sa pagpapatakbo	2.48B	-0.68%
Net na kita	1.51B	13.48%
Net profit margin	14.54	13.24%
Kita sa bawat share	5.15	0.78%
EBITDA	2.54B	-0.78%
Aktuwal na % ng binabayarang buwis	5.92%	—

Balance Sheet

Kabuuang asset

Kabuuang sagutin

(USD)	Mar 2025	Y/Y na pagbabago
Cash at mga panandaliang investment	5.95B	-17.97%
Kabuuang asset	99.04B	2.00%
Kabuuang sagutin	49.56B	-3.72%
Kabuuang equity	49.48B	—
Natitirang share	378.00M	—
Presyo para makapag-book	2.85	—
Return on assets	4.67%	—
Return on capital	5.52%	—

Cash Flow

Net change in cash

(USD)	Mar 2025	Y/Y na pagbabago
Net na kita	1.51B	13.48%
Cash mula sa mga operasyon	723.00M	-42.21%
Cash mula sa pag-invest	-527.00M	74.04%
Cash mula sa financing	-102.00M	94.40%
Net change in cash	132.00M	105.12%
Malayang cash flow	-64.50M	-107.34%

Tungkol

Thermo Fisher Scientific Inc. is an American life science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation, Alfa Aesar, Affymetrix, FEI Company, BD Advanced Bioprocessing, and PPD. As of 2023, the company had a market capitalization of $202 billion. It ranked 97th on the Fortune 500 list based on its 2022 annual revenue of US$44.92 billion. Wikipedia

CEO

Marc N. Casper

Itinatag

1956

Headquarters

Waltham, Massachusetts
Estados Unidos

Website

thermofisher.com

Mga Empleyado

125,000